Valiant Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Organics has filed its audited Q4 and FY25 results with an un-modified (clean) auditor opinion from Gokhale & Sathe. On a standalone basis, revenue grew about 6% YoY to Rs 718.76 crore and the company swung back to a net profit of roughly Rs 12 crore, compared with a loss of Rs 3.04 crore in FY24. On a consolidated basis, revenue dipped marginally to Rs 718.76 crore from Rs 723.06 crore, and the net loss narrowed to Rs 3.43 crore from Rs 8.40 crore. The company's A-1-210 plant in Ahmedabad was disrupted by a fire on October 21, 2024, and has since resumed operations from May 20, 2025, with an insurance claim filed. The board also allotted 4,05,561 bonus equity shares to OCPS holders and re-appointed the Cost Auditor and Internal Auditor for FY26.
The standalone turnaround to profit is encouraging, but the consolidated entity remains in the red, partly because Valiant Labs is now classified as an associate rather than a subsidiary. Investors should watch plant recovery post-fire and the outcome of the insurance claim, which could provide a one-time boost to FY26 earnings.